Aspen Pharmacare
Aspen is a global specialty and branded multinational pharmaceutical company with a 170-year heritage.
Last updated September 11, 2026
AI crawler reads
4requests
1companies- Anthropic4
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Aspen is a global specialty and branded multinational pharmaceutical company with a 170-year heritage and a presence in both emerging and developed markets. It focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through its key business segments: Manufacturing and Commercial Pharmaceuticals comprising Injectable products, Prescription and OTC medicines. Its manufacturing capabilities cover steriles, oral solid dose, liquids, semi-solids, biologicals and active pharmaceutical ingredients, and it operates 24 manufacturing facilities across 15 sites.
History
With a 170-year heritage, Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets. It focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through its key business segments: Manufacturing and Commercial Pharmaceuticals comprising Injectable products, Prescription and OTC medicines.
Recent events
Reported
Acino agrees to acquire selected Aspen medicines in South Africa[5]
Acino and Aspen signed an agreement for Acino to acquire six South African prescription medicines for over €105 million (R1.8 billion).
Reported
Mylan to acquire Aspen's European thrombosis portfolio[6]
Mylan agreed to acquire Aspen's European thrombosis business for €641.9 million. The deal was expected to close before December 25, 2021; Aspen would continue manufacturing and supplying the drugs.
Sources6 sources
Cite this profile: Cite the canonical profile. /brand-wiki/aspen-pharmacare · Editorial policy · How profiles are compiled